AstraZeneca's Imfinzi granted EC approval for limited-stage small cell lung cancer - PMLiVE

Retrieved on: 2025-03-20 12:21:24

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca's Imfinzi granted EC approval for limited-stage small cell lung cancer - PMLiVE. View article details on hiswai:

Excerpt

AstraZeneca (AZ) has announced that its immunotherapy Imfinzi (durvalumab) has been approved by the European Commission (EC) to treat adults with ...

Article found on: pmlive.com